# Low-dose Buprenorphine Initiation for Opioid Use Disorder

> **NCT05450718** · PHASE4 · RECRUITING · sponsor: **Montefiore Medical Center** · enrollment: 70 (estimated)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** buprenorphine-naloxone
- **DRUG:** buprenorphine-naloxone

## Key facts

- **NCT ID:** NCT05450718
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-11
- **Primary completion:** 2027-03-17
- **Final completion:** 2027-06-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05450718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05450718, "Low-dose Buprenorphine Initiation for Opioid Use Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05450718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*